Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monoclonal antibodies: magic bullets with a hefty price tag.

Literature DB >> 23236036

Monoclonal antibodies: magic bullets with a hefty price tag.

Allen F Shaughnessy¹.

Abstract

Mesh：

Substances：

Year: 2012 PMID： 23236036 DOI： 10.1136/bmj.e8346

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

Keyword Cloud
Cited

× No keyword cloud information.

32 in total

Review 1. Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors: Olivia Giddings; Charles R Esther
Journal: Pediatr Pulmonol Date: 2017-07-17

Review 2. Clinical promise of next-generation complement therapeutics.

Authors: Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal: Nat Rev Drug Discov Date: 2019-07-19 Impact factor: 84.694

3. Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease.

Authors: Ganna Tolstanova; Xiaoming Deng; Amrita Ahluwalia; Brankica Paunovic; Alona Prysiazhniuk; Lyudmyla Ostapchenko; Andrzej Tarnawski; Zsuzsanna Sandor; Sandor Szabo
Journal: Dig Dis Sci Date: 2015-05-14 Impact factor: 3.199

Review 4. Targeting the complement cascade: novel treatments coming down the pike.

Authors: Joshua M Thurman; Moglie Le Quintrec
Journal: Kidney Int Date: 2016-06-18 Impact factor: 10.612

Review 5. Prioritization schema for immunotherapy clinical trials in glioblastoma.

Authors: Tiffany R Hodges; Sherise D Ferguson; Hillary G Caruso; Gary Kohanbash; Shouhao Zhou; Timothy F Cloughesy; Mitchel S Berger; George H Poste; Mustafa Khasraw; Sujuan Ba; Tao Jiang; Tom Mikkelson; W K Alfred Yung; John F de Groot; Howard Fine; Lewis C Cantley; Ingo K Mellinghoff; Duane A Mitchell; Hideho Okada; Amy B Heimberger
Journal: Oncoimmunology Date: 2016-02-18 Impact factor: 8.110

Review 6. Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?

Authors: Cassandra M Berry
Journal: Hum Vaccin Immunother Date: 2017-11-07 Impact factor: 3.452

Review 7. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications.

Authors: Erika Vacchelli; Jonathan Pol; Norma Bloy; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jérôme Galon; Aurélien Marabelle; Holbrook Kohrt; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal: Oncoimmunology Date: 2015-02-03 Impact factor: 8.110